Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Cancer
Interventions: DRUG: irinotecan hydrochloride|DRUG: temozolomide
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)